Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

Abstract Background Nivolumab is used for the treatment of malignant pleural mesothelioma (MPM). However, immune-related adverse events (irAEs) occur in patients treated with nivolumab. Several studies have reported the correlation between irAEs and therapeutic effects of immune checkpoint inhibitor...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Hirokazu Ogino, Kenji Otsuka, Yasuhiko Nishioka
Format: article
Language:EN
Published: BMC 2021
Subjects:
Online Access:https://doaj.org/article/283e2c804e1e4caca2a024bc86d5df46
Tags: Add Tag
No Tags, Be the first to tag this record!